title: Generating ceramide from sphingomyelin by alkaline sphingomyelinase in the gut enhances sphingomyelin-induced inhibition of cholesterol uptake in Caco-2 cells.
abstract: Background Sphingomyelin (SM) is present in dietary products and cell plasma membranes. We previously showed that dietary SM inhibited cholesterol absorption in rats. In the intestinal tract, SM is mainly hydrolyzed by alkaline sphingomyelinase (alk-SMase) to ceramide.Aims We investigated the influence of SM and its hydrolytic products ceramide and sphingosine on cholesterol uptake in intestinal Caco-2 cells.Methods Micelles containing bile salt, monoolein, and (14)C-cholesterol were prepared with or without SM, ceramide,or sphingosine. The micelles were incubated with Caco-2 cells, and uptake of radioactive cholesterol was quantified.Results We found that confluent monolayer Caco-2 cells expressed NPC1L1, and the uptake of cholesterol in the cells was inhibited by ezetimibe, a specific inhibitor of NPC1L1. Incorporation of SM in the cholesterol micelles inhibited cholesterol uptake dose-dependently; 38% inhibition occurred at an equal mole ratio of SM and cholesterol.The inhibition was further enhanced to 45% by pretreating the cholesterol/SM micelles with recombinant alk-SMase, which hydrolyzed SM in the micelles by 85%, indicating ceramide has stronger inhibitory effects on cholesterol uptake. To confirm this, we further replaced SM in the micelles with ceramide and sphingosine, and found that at equal mole ratio to cholesterol, ceramide exhibited stronger inhibitory effect (50% vs 38%) on cholesterol uptake than SM, whereas sphingosine only had a weak effect at high concentrations.Conclusion Both SM and ceramide inhibit cholesterol uptake, the effect of ceramide being stronger than that of SM. Alk-SMase enhances SM-induced inhibition of cholesterol uptake by generating ceramide in the intestinal lumen.
authors.affiliation: Gastroenterology and Nutrition Laboratory, Biomedical CenterB11, Institution of Clinical Sciences, University of Lund,221 84 Lund, Sweden.
authors.forename: Dan
authors.initials: D
authors.lastname: Feng
authors.forename: Lena
authors.initials: L
authors.lastname: Ohlsson
authors.forename: Wenhua
authors.initials: W
authors.lastname: Ling
authors.forename: Ake
authors.initials: A
authors.lastname: Nilsson
authors.forename: Rui-Dong
authors.initials: RD
authors.lastname: Duan
mesh_terms: D018938:Caco-2 Cells; D002518:Ceramides / Q000096:biosynthesis*; D002784:Cholesterol / Q000378:metabolism*; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism*; D013108:Sphingomyelin Phosphodiesterase / Q000378:metabolism*; D013109:Sphingomyelins / Q000378:metabolism*
chemical_list: D002518:Ceramides; D013109:Sphingomyelins; D002784:Cholesterol; D013108:Sphingomyelin Phosphodiesterase
references.citation: Trends Biochem Sci. 2005 Oct;30(10):542-50
references.pmid: 16125936
references.citation: Biochimie. 2007 Aug;89(8):950-60
references.pmid: 17475390
references.citation: Dig Dis Sci. 1996 Sep;41(9):1801-6
references.pmid: 8794797
references.citation: J Atheroscler Thromb. 2007 Jun;14(3):99-108
references.pmid: 17587760
references.citation: J Lipid Res. 1990 Mar;31(3):515-21
references.pmid: 2160511
references.citation: Biochim Biophys Acta. 1996 Mar 29;1300(1):42-8
references.pmid: 8608160
references.citation: J Nutr. 1992 Aug;122(8):1656-61
references.pmid: 1640259
references.citation: Biochemistry. 2006 Oct 17;45(41):12629-38
references.pmid: 17029417
references.citation: J Lipid Res. 2002 Feb;43(2):316-24
references.pmid: 11861674
references.citation: J Lipid Res. 1991 Nov;32(11):1811-21
references.pmid: 1770301
references.citation: J Biol Chem. 2004 Aug 6;279(32):33586-92
references.pmid: 15173162
references.citation: J Biol Chem. 2003 Oct 3;278(40):38528-36
references.pmid: 12885774
references.citation: Can J Biochem Physiol. 1959 Aug;37(8):911-7
references.pmid: 13671378
references.citation: J Lipid Res. 2006 Jan;47(1):154-71
references.pmid: 16251722
references.citation: Biochim Biophys Acta. 1968 Dec 18;164(3):575-84
references.pmid: 5701698
references.citation: Gastroenterology. 2002 Apr;122(4):948-56
references.pmid: 11910347
references.citation: Biochim Biophys Acta. 2006 Dec;1758(12):1945-56
references.pmid: 16901461
references.citation: J Nutr. 2004 Oct;134(10):2611-6
references.pmid: 15465755
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):856-62
references.pmid: 15824156
references.citation: Biochim Biophys Acta. 1977 Feb 14;465(1):1-10
references.pmid: 836830
references.citation: Cancer. 1997 Feb 1;79(3):448-53
references.pmid: 9028353
references.citation: J Nutr Biochem. 2000 May;11(5):244-9
references.pmid: 10876096
references.citation: Biochim Biophys Acta. 1969 Mar 4;176(2):339-47
references.pmid: 5775951
references.citation: Dig Dis Sci. 2001 Apr;46(4):765-72
references.pmid: 11330410
references.citation: Biochem J. 1992 Sep 15;286 ( Pt 3):771-7
references.pmid: 1417735
references.citation: Dig Dis Sci. 1998 Jan;43(1):26-32
references.pmid: 9508530
references.citation: Am J Physiol Gastrointest Liver Physiol. 2004 Nov;287(5):G967-73
references.pmid: 15205117
references.citation: Dig Dis Sci. 2009 Jul;54(7):1440-8
references.pmid: 18989780
references.citation: Curr Opin Lipidol. 1999 Aug;10(4):315-20
references.pmid: 10482134
references.citation: J Lipid Res. 2005 Jan;46(1):36-45
references.pmid: 15520452
references.citation: J Lipid Res. 1993 Dec;34(12):2159-67
references.pmid: 8301234
references.citation: J Lipid Res. 2003 Jun;44(6):1241-50
references.pmid: 12671034
references.citation: J Nutr. 1986 Jan;116(1):50-8
references.pmid: 3944656
references.citation: Biochim Biophys Acta. 2002 May 10;1571(1):34-44
references.pmid: 12031288
references.citation: Biochim Biophys Acta. 2006 Mar;1761(3):281-91
references.pmid: 16631405
references.citation: Biochemistry. 1996 Jun 18;35(24):8025-34
references.pmid: 8672507
references.citation: Atherosclerosis. 1995 Oct;117(2):305-8
references.pmid: 8801876